✔ 100% Authentic Product
👁️ Currently Viewing 454
Darbagen 100mcg/0.5ml SC Injection
Darbagen is indicated for the treatment of anemia caused by:
- Chronic Kidney Disease (CKD) in patients on dialysis and those not on dialysis.
- The effects of myelosuppressive chemotherapy, particularly when starting chemotherapy and continuing for at least two additional months.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Cash on Delivery - All over Bangladesh
Regular Delivery - 8-12 Hours, Dhaka City*- Regular Delivery - 24-48 Hours, All Over Bangladesh*
✅ Description:
Darbepoetin alfa is an erythropoiesis-stimulating protein produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cells. It is a 165-amino acid protein that differs from recombinant human erythropoietin by containing 5 N-linked oligosaccharide chains (compared to the 3 chains in recombinant human erythropoietin). These extra glycosylation sites are due to amino acid substitutions in the peptide backbone.
Relevant Products / প্রাসঙ্গিক পণ্য
✔️ Side Effects
- Hypertension
- Stroke
- Thromboembolic events
- Convulsions
- Allergic reactions
- Rash/erythema
- Pure Red Cell Aplasia (PRCA)
✔️ Chronic Renal Failure (Adult & Pediatric):
Correction phase: Initial dose is 0.45 µg/kg body weight, given subcutaneously or intravenously once a week. Alternative doses for patients not on dialysis: 0.75 µg/kg every two weeks or 1.5 µg/kg once a month.
- Maintenance phase: In dialysis patients, continue the dose weekly or every two weeks. In non-dialysis patients, doses may also be administered weekly, bi-weekly, or monthly.
✔️ Pediatric population (≥1 year):
- Correction phase: Initial dose is 0.45 µg/kg body weight, subcutaneously or intravenously, once a week or 0.75 µg/kg every two weeks for non-dialysis patients.
- Maintenance phase: Ongoing dosing based on age, with patients under 6 years potentially needing higher doses. Monthly dosing is an option for those ≥11 years after achieving target hemoglobin.
✔️ Symptomatic Chemotherapy-Induced Anemia:
- Initial Dose: 500 µg (6.75 µg/kg) once every three weeks, or alternatively, 2.25 µg/kg weekly. Treatment should be reevaluated if there's inadequate response after 9 weeks.
✔️ Administration
- Do not shake or freeze Darbepoetin alfa.
- Protect the pre-filled syringe from light.
- Inspect the syringe for particulate matter or discoloration before use. Do not use if these are present.
- Discard any unused portion of the syringe.
- Do not dilute Darbepoetin alfa or administer with other drug solutions.
✔️ Interaction
- No formal drug interaction studies have been conducted with Darbagen.
✔️ Contraindications
- Uncontrolled hypertension
- Pure Red Cell Aplasia (PRCA)
- Serious allergic reactions
✔️ Pregnancy & Lactation
- Pregnancy Category C. The excretion of Darbepoetin alfa in human milk is unknown. Use caution when administering to breastfeeding women.
✔️ Precautions & Warnings
- Use cautiously in patients with controlled hypertension, a history of seizures, PRCA, or suspected allergies to the product.
✔️ Storage Conditions
- Store at 2°C to 8°C. Do not freeze.
- Protect it from light and keep it in the carton until use.
- Do not use if shaken or frozen.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.
